nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A5—Daunorubicin—hematologic cancer	0.0498	0.0686	CbGbCtD
Dutasteride—CYP3A5—Thalidomide—hematologic cancer	0.0454	0.0625	CbGbCtD
Dutasteride—CYP3A5—Teniposide—hematologic cancer	0.0433	0.0596	CbGbCtD
Dutasteride—CYP3A5—Ifosfamide—hematologic cancer	0.04	0.055	CbGbCtD
Dutasteride—CYP3A5—Imatinib—hematologic cancer	0.0382	0.0525	CbGbCtD
Dutasteride—CYP3A4—Bexarotene—hematologic cancer	0.0331	0.0456	CbGbCtD
Dutasteride—CYP3A4—Lomustine—hematologic cancer	0.0308	0.0424	CbGbCtD
Dutasteride—CYP3A4—Busulfan—hematologic cancer	0.0308	0.0424	CbGbCtD
Dutasteride—CYP3A5—Dasatinib—hematologic cancer	0.0307	0.0422	CbGbCtD
Dutasteride—CYP3A4—Thiotepa—hematologic cancer	0.0275	0.0378	CbGbCtD
Dutasteride—CYP3A5—Irinotecan—hematologic cancer	0.0238	0.0328	CbGbCtD
Dutasteride—CYP3A4—Methoxsalen—hematologic cancer	0.0214	0.0294	CbGbCtD
Dutasteride—CYP3A5—Vincristine—hematologic cancer	0.0208	0.0287	CbGbCtD
Dutasteride—CYP3A4—Bortezomib—hematologic cancer	0.0203	0.028	CbGbCtD
Dutasteride—CYP3A4—Daunorubicin—hematologic cancer	0.0194	0.0267	CbGbCtD
Dutasteride—CYP3A5—Etoposide—hematologic cancer	0.0191	0.0263	CbGbCtD
Dutasteride—CYP3A4—Cytarabine—hematologic cancer	0.0171	0.0236	CbGbCtD
Dutasteride—CYP3A4—Teniposide—hematologic cancer	0.0169	0.0232	CbGbCtD
Dutasteride—CYP3A5—Dexamethasone—hematologic cancer	0.0157	0.0216	CbGbCtD
Dutasteride—CYP3A4—Ifosfamide—hematologic cancer	0.0156	0.0214	CbGbCtD
Dutasteride—CYP3A4—Imatinib—hematologic cancer	0.0149	0.0205	CbGbCtD
Dutasteride—CYP3A4—Ruxolitinib—hematologic cancer	0.014	0.0193	CbGbCtD
Dutasteride—CYP3A4—Nilotinib—hematologic cancer	0.0135	0.0186	CbGbCtD
Dutasteride—CYP3A4—Vinorelbine—hematologic cancer	0.0134	0.0185	CbGbCtD
Dutasteride—CYP3A4—Triamcinolone—hematologic cancer	0.0123	0.0169	CbGbCtD
Dutasteride—CYP3A4—Dasatinib—hematologic cancer	0.012	0.0165	CbGbCtD
Dutasteride—CYP3A4—Mitoxantrone—hematologic cancer	0.0118	0.0162	CbGbCtD
Dutasteride—CYP3A4—Betamethasone—hematologic cancer	0.0105	0.0145	CbGbCtD
Dutasteride—CYP3A4—Prednisolone—hematologic cancer	0.0104	0.0143	CbGbCtD
Dutasteride—CYP3A4—Prednisone—hematologic cancer	0.00981	0.0135	CbGbCtD
Dutasteride—CYP3A4—Irinotecan—hematologic cancer	0.0093	0.0128	CbGbCtD
Dutasteride—CYP3A4—Vinblastine—hematologic cancer	0.00827	0.0114	CbGbCtD
Dutasteride—CYP3A4—Vincristine—hematologic cancer	0.00813	0.0112	CbGbCtD
Dutasteride—CYP3A4—Etoposide—hematologic cancer	0.00745	0.0102	CbGbCtD
Dutasteride—CYP3A4—Dexamethasone—hematologic cancer	0.00612	0.00842	CbGbCtD
Dutasteride—CYP3A4—Doxorubicin—hematologic cancer	0.00508	0.00699	CbGbCtD
Dutasteride—Dizziness—Nelarabine—hematologic cancer	0.000321	0.00133	CcSEcCtD
Dutasteride—Pruritus—Pentostatin—hematologic cancer	0.00032	0.00133	CcSEcCtD
Dutasteride—Pruritus—Anagrelide—hematologic cancer	0.00032	0.00133	CcSEcCtD
Dutasteride—Mental disorder—Thiotepa—hematologic cancer	0.000317	0.00132	CcSEcCtD
Dutasteride—Cardiac failure—Dexamethasone—hematologic cancer	0.000316	0.00132	CcSEcCtD
Dutasteride—Cardiac failure—Betamethasone—hematologic cancer	0.000316	0.00132	CcSEcCtD
Dutasteride—Immune system disorder—Thalidomide—hematologic cancer	0.000316	0.00131	CcSEcCtD
Dutasteride—Neoplasm malignant—Doxorubicin—hematologic cancer	0.000314	0.0013	CcSEcCtD
Dutasteride—Dizziness—Methoxsalen—hematologic cancer	0.000313	0.0013	CcSEcCtD
Dutasteride—Hypersensitivity—Teniposide—hematologic cancer	0.000312	0.0013	CcSEcCtD
Dutasteride—Urticaria—Busulfan—hematologic cancer	0.000312	0.0013	CcSEcCtD
Dutasteride—Angioedema—Bortezomib—hematologic cancer	0.000308	0.00128	CcSEcCtD
Dutasteride—Breast pain—Doxorubicin—hematologic cancer	0.000307	0.00128	CcSEcCtD
Dutasteride—Mental disorder—Thalidomide—hematologic cancer	0.000306	0.00127	CcSEcCtD
Dutasteride—Urticaria—Procarbazine—hematologic cancer	0.000303	0.00126	CcSEcCtD
Dutasteride—Angioedema—Vinorelbine—hematologic cancer	0.000301	0.00125	CcSEcCtD
Dutasteride—Dizziness—Clofarabine—hematologic cancer	0.0003	0.00125	CcSEcCtD
Dutasteride—Dizziness—Daunorubicin—hematologic cancer	0.0003	0.00125	CcSEcCtD
Dutasteride—Pruritus—Teniposide—hematologic cancer	0.0003	0.00125	CcSEcCtD
Dutasteride—Dizziness—Anagrelide—hematologic cancer	0.000299	0.00124	CcSEcCtD
Dutasteride—Dizziness—Pentostatin—hematologic cancer	0.000299	0.00124	CcSEcCtD
Dutasteride—Rash—Methoxsalen—hematologic cancer	0.000299	0.00124	CcSEcCtD
Dutasteride—Dermatitis—Methoxsalen—hematologic cancer	0.000298	0.00124	CcSEcCtD
Dutasteride—Immune system disorder—Ifosfamide—hematologic cancer	0.000297	0.00123	CcSEcCtD
Dutasteride—Urticaria—Dasatinib—hematologic cancer	0.000297	0.00123	CcSEcCtD
Dutasteride—Mental disorder—Carmustine—hematologic cancer	0.000294	0.00122	CcSEcCtD
Dutasteride—Mental disorder—Alitretinoin—hematologic cancer	0.000291	0.00121	CcSEcCtD
Dutasteride—Rash—Mercaptopurine—hematologic cancer	0.00029	0.00121	CcSEcCtD
Dutasteride—Dermatitis—Mercaptopurine—hematologic cancer	0.00029	0.00121	CcSEcCtD
Dutasteride—Hypersensitivity—Busulfan—hematologic cancer	0.000289	0.0012	CcSEcCtD
Dutasteride—Mental disorder—Ifosfamide—hematologic cancer	0.000288	0.0012	CcSEcCtD
Dutasteride—Rash—Clofarabine—hematologic cancer	0.000286	0.00119	CcSEcCtD
Dutasteride—Rash—Daunorubicin—hematologic cancer	0.000286	0.00119	CcSEcCtD
Dutasteride—Dermatitis—Clofarabine—hematologic cancer	0.000286	0.00119	CcSEcCtD
Dutasteride—Dermatitis—Daunorubicin—hematologic cancer	0.000286	0.00119	CcSEcCtD
Dutasteride—Rash—Pentostatin—hematologic cancer	0.000285	0.00118	CcSEcCtD
Dutasteride—Rash—Anagrelide—hematologic cancer	0.000285	0.00118	CcSEcCtD
Dutasteride—Dermatitis—Pentostatin—hematologic cancer	0.000285	0.00118	CcSEcCtD
Dutasteride—Dermatitis—Anagrelide—hematologic cancer	0.000285	0.00118	CcSEcCtD
Dutasteride—Immune system disorder—Irinotecan—hematologic cancer	0.000282	0.00117	CcSEcCtD
Dutasteride—Hypersensitivity—Procarbazine—hematologic cancer	0.000281	0.00117	CcSEcCtD
Dutasteride—Mental disorder—Vincristine—hematologic cancer	0.000281	0.00117	CcSEcCtD
Dutasteride—Urticaria—Chlorambucil—hematologic cancer	0.00028	0.00117	CcSEcCtD
Dutasteride—Neoplasm—Methotrexate—hematologic cancer	0.00028	0.00116	CcSEcCtD
Dutasteride—Angioedema—Thalidomide—hematologic cancer	0.000278	0.00116	CcSEcCtD
Dutasteride—Pruritus—Busulfan—hematologic cancer	0.000278	0.00116	CcSEcCtD
Dutasteride—Gynaecomastia—Methotrexate—hematologic cancer	0.000277	0.00115	CcSEcCtD
Dutasteride—Cardiac failure—Prednisone—hematologic cancer	0.000275	0.00115	CcSEcCtD
Dutasteride—Hypersensitivity—Bexarotene—hematologic cancer	0.000275	0.00114	CcSEcCtD
Dutasteride—Hypersensitivity—Dasatinib—hematologic cancer	0.000275	0.00114	CcSEcCtD
Dutasteride—Rash—Idarubicin—hematologic cancer	0.000275	0.00114	CcSEcCtD
Dutasteride—Immune system disorder—Gemcitabine—hematologic cancer	0.000275	0.00114	CcSEcCtD
Dutasteride—Dermatitis—Idarubicin—hematologic cancer	0.000274	0.00114	CcSEcCtD
Dutasteride—Hypersensitivity—Fludarabine—hematologic cancer	0.000274	0.00114	CcSEcCtD
Dutasteride—Urticaria—Nilotinib—hematologic cancer	0.000274	0.00114	CcSEcCtD
Dutasteride—Urticaria—Imatinib—hematologic cancer	0.000273	0.00113	CcSEcCtD
Dutasteride—Pruritus—Procarbazine—hematologic cancer	0.00027	0.00112	CcSEcCtD
Dutasteride—Urticaria—Cladribine—hematologic cancer	0.000268	0.00111	CcSEcCtD
Dutasteride—Rash—Teniposide—hematologic cancer	0.000267	0.00111	CcSEcCtD
Dutasteride—Dermatitis—Teniposide—hematologic cancer	0.000267	0.00111	CcSEcCtD
Dutasteride—Pruritus—Dasatinib—hematologic cancer	0.000264	0.0011	CcSEcCtD
Dutasteride—Pruritus—Bexarotene—hematologic cancer	0.000264	0.0011	CcSEcCtD
Dutasteride—Pruritus—Fludarabine—hematologic cancer	0.000264	0.0011	CcSEcCtD
Dutasteride—Neoplasm—Epirubicin—hematologic cancer	0.000262	0.00109	CcSEcCtD
Dutasteride—Angioedema—Ifosfamide—hematologic cancer	0.000261	0.00109	CcSEcCtD
Dutasteride—Hypersensitivity—Chlorambucil—hematologic cancer	0.00026	0.00108	CcSEcCtD
Dutasteride—Dizziness—Busulfan—hematologic cancer	0.00026	0.00108	CcSEcCtD
Dutasteride—Immune system disorder—Cisplatin—hematologic cancer	0.000256	0.00106	CcSEcCtD
Dutasteride—Hypersensitivity—Nilotinib—hematologic cancer	0.000254	0.00106	CcSEcCtD
Dutasteride—Hypersensitivity—Imatinib—hematologic cancer	0.000253	0.00105	CcSEcCtD
Dutasteride—Dizziness—Procarbazine—hematologic cancer	0.000252	0.00105	CcSEcCtD
Dutasteride—Pruritus—Chlorambucil—hematologic cancer	0.00025	0.00104	CcSEcCtD
Dutasteride—Hypersensitivity—Cladribine—hematologic cancer	0.000248	0.00103	CcSEcCtD
Dutasteride—Rash—Busulfan—hematologic cancer	0.000248	0.00103	CcSEcCtD
Dutasteride—Dermatitis—Busulfan—hematologic cancer	0.000247	0.00103	CcSEcCtD
Dutasteride—Dizziness—Dasatinib—hematologic cancer	0.000247	0.00103	CcSEcCtD
Dutasteride—Dizziness—Bexarotene—hematologic cancer	0.000247	0.00103	CcSEcCtD
Dutasteride—Urticaria—Melphalan—hematologic cancer	0.000244	0.00102	CcSEcCtD
Dutasteride—Pruritus—Nilotinib—hematologic cancer	0.000244	0.00102	CcSEcCtD
Dutasteride—Pruritus—Imatinib—hematologic cancer	0.000243	0.00101	CcSEcCtD
Dutasteride—Neoplasm—Doxorubicin—hematologic cancer	0.000242	0.00101	CcSEcCtD
Dutasteride—Rash—Procarbazine—hematologic cancer	0.00024	0.000999	CcSEcCtD
Dutasteride—Dermatitis—Procarbazine—hematologic cancer	0.00024	0.000998	CcSEcCtD
Dutasteride—Pruritus—Cladribine—hematologic cancer	0.000239	0.000992	CcSEcCtD
Dutasteride—Hypersensitivity—Vinblastine—hematologic cancer	0.000238	0.000991	CcSEcCtD
Dutasteride—Urticaria—Lenalidomide—hematologic cancer	0.000238	0.000988	CcSEcCtD
Dutasteride—Rash—Bexarotene—hematologic cancer	0.000236	0.000979	CcSEcCtD
Dutasteride—Rash—Dasatinib—hematologic cancer	0.000236	0.000979	CcSEcCtD
Dutasteride—Dermatitis—Bexarotene—hematologic cancer	0.000235	0.000978	CcSEcCtD
Dutasteride—Dermatitis—Dasatinib—hematologic cancer	0.000235	0.000978	CcSEcCtD
Dutasteride—Rash—Fludarabine—hematologic cancer	0.000235	0.000977	CcSEcCtD
Dutasteride—Dermatitis—Fludarabine—hematologic cancer	0.000235	0.000976	CcSEcCtD
Dutasteride—Immune system disorder—Etoposide—hematologic cancer	0.000234	0.000975	CcSEcCtD
Dutasteride—Dizziness—Nilotinib—hematologic cancer	0.000228	0.000949	CcSEcCtD
Dutasteride—Dizziness—Imatinib—hematologic cancer	0.000227	0.000944	CcSEcCtD
Dutasteride—Hypersensitivity—Melphalan—hematologic cancer	0.000227	0.000942	CcSEcCtD
Dutasteride—Dizziness—Cladribine—hematologic cancer	0.000223	0.000927	CcSEcCtD
Dutasteride—Hypersensitivity—Lenalidomide—hematologic cancer	0.00022	0.000916	CcSEcCtD
Dutasteride—Urticaria—Bortezomib—hematologic cancer	0.000219	0.000909	CcSEcCtD
Dutasteride—Pruritus—Melphalan—hematologic cancer	0.000218	0.000905	CcSEcCtD
Dutasteride—Rash—Nilotinib—hematologic cancer	0.000218	0.000905	CcSEcCtD
Dutasteride—Dermatitis—Nilotinib—hematologic cancer	0.000217	0.000904	CcSEcCtD
Dutasteride—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000217	0.000903	CcSEcCtD
Dutasteride—Urticaria—Bleomycin—hematologic cancer	0.000217	0.000902	CcSEcCtD
Dutasteride—Rash—Imatinib—hematologic cancer	0.000216	0.0009	CcSEcCtD
Dutasteride—Dermatitis—Imatinib—hematologic cancer	0.000216	0.000899	CcSEcCtD
Dutasteride—Cardiac failure—Epirubicin—hematologic cancer	0.000215	0.000896	CcSEcCtD
Dutasteride—Erectile dysfunction—Prednisone—hematologic cancer	0.000214	0.00089	CcSEcCtD
Dutasteride—Dizziness—Vinblastine—hematologic cancer	0.000214	0.000889	CcSEcCtD
Dutasteride—Urticaria—Vinorelbine—hematologic cancer	0.000214	0.000888	CcSEcCtD
Dutasteride—Rash—Cladribine—hematologic cancer	0.000213	0.000884	CcSEcCtD
Dutasteride—Dermatitis—Cladribine—hematologic cancer	0.000212	0.000883	CcSEcCtD
Dutasteride—Pruritus—Lenalidomide—hematologic cancer	0.000212	0.00088	CcSEcCtD
Dutasteride—Urticaria—Thiotepa—hematologic cancer	0.000204	0.000848	CcSEcCtD
Dutasteride—Angioedema—Prednisolone—hematologic cancer	0.000204	0.000846	CcSEcCtD
Dutasteride—Breast disorder—Methotrexate—hematologic cancer	0.000203	0.000844	CcSEcCtD
Dutasteride—Hypersensitivity—Bortezomib—hematologic cancer	0.000203	0.000843	CcSEcCtD
Dutasteride—Hypersensitivity—Bleomycin—hematologic cancer	0.000201	0.000837	CcSEcCtD
Dutasteride—Cardiac failure—Doxorubicin—hematologic cancer	0.000199	0.000829	CcSEcCtD
Dutasteride—Hypersensitivity—Vinorelbine—hematologic cancer	0.000198	0.000823	CcSEcCtD
Dutasteride—Dizziness—Lenalidomide—hematologic cancer	0.000198	0.000822	CcSEcCtD
Dutasteride—Urticaria—Thalidomide—hematologic cancer	0.000197	0.00082	CcSEcCtD
Dutasteride—Dizziness—Hydroxyurea—hematologic cancer	0.000195	0.000811	CcSEcCtD
Dutasteride—Pruritus—Bortezomib—hematologic cancer	0.000195	0.00081	CcSEcCtD
Dutasteride—Rash—Melphalan—hematologic cancer	0.000194	0.000806	CcSEcCtD
Dutasteride—Dermatitis—Melphalan—hematologic cancer	0.000194	0.000806	CcSEcCtD
Dutasteride—Pruritus—Bleomycin—hematologic cancer	0.000193	0.000803	CcSEcCtD
Dutasteride—Pruritus—Vinorelbine—hematologic cancer	0.00019	0.000791	CcSEcCtD
Dutasteride—Breast disorder—Epirubicin—hematologic cancer	0.00019	0.00079	CcSEcCtD
Dutasteride—Hypersensitivity—Thiotepa—hematologic cancer	0.000189	0.000786	CcSEcCtD
Dutasteride—Rash—Lenalidomide—hematologic cancer	0.000189	0.000784	CcSEcCtD
Dutasteride—Dermatitis—Lenalidomide—hematologic cancer	0.000188	0.000783	CcSEcCtD
Dutasteride—Urticaria—Alitretinoin—hematologic cancer	0.000188	0.00078	CcSEcCtD
Dutasteride—Angioedema—Triamcinolone—hematologic cancer	0.000187	0.000778	CcSEcCtD
Dutasteride—Rash—Hydroxyurea—hematologic cancer	0.000186	0.000773	CcSEcCtD
Dutasteride—Dermatitis—Hydroxyurea—hematologic cancer	0.000186	0.000772	CcSEcCtD
Dutasteride—Urticaria—Ifosfamide—hematologic cancer	0.000185	0.000771	CcSEcCtD
Dutasteride—Hypersensitivity—Thalidomide—hematologic cancer	0.000183	0.00076	CcSEcCtD
Dutasteride—Dizziness—Bortezomib—hematologic cancer	0.000182	0.000757	CcSEcCtD
Dutasteride—Pruritus—Thiotepa—hematologic cancer	0.000182	0.000755	CcSEcCtD
Dutasteride—Erectile dysfunction—Methotrexate—hematologic cancer	0.000179	0.000744	CcSEcCtD
Dutasteride—Dizziness—Vinorelbine—hematologic cancer	0.000178	0.000739	CcSEcCtD
Dutasteride—Urticaria—Mitoxantrone—hematologic cancer	0.000176	0.000732	CcSEcCtD
Dutasteride—Breast disorder—Doxorubicin—hematologic cancer	0.000176	0.000731	CcSEcCtD
Dutasteride—Hypersensitivity—Carmustine—hematologic cancer	0.000176	0.00073	CcSEcCtD
Dutasteride—Pruritus—Thalidomide—hematologic cancer	0.000176	0.00073	CcSEcCtD
Dutasteride—Hypersensitivity—Alitretinoin—hematologic cancer	0.000174	0.000723	CcSEcCtD
Dutasteride—Rash—Bortezomib—hematologic cancer	0.000174	0.000722	CcSEcCtD
Dutasteride—Dermatitis—Bortezomib—hematologic cancer	0.000173	0.000721	CcSEcCtD
Dutasteride—Rash—Bleomycin—hematologic cancer	0.000172	0.000716	CcSEcCtD
Dutasteride—Dermatitis—Bleomycin—hematologic cancer	0.000172	0.000715	CcSEcCtD
Dutasteride—Hypersensitivity—Ifosfamide—hematologic cancer	0.000172	0.000715	CcSEcCtD
Dutasteride—Angioedema—Dexamethasone—hematologic cancer	0.00017	0.000706	CcSEcCtD
Dutasteride—Angioedema—Betamethasone—hematologic cancer	0.00017	0.000706	CcSEcCtD
Dutasteride—Dizziness—Thiotepa—hematologic cancer	0.00017	0.000706	CcSEcCtD
Dutasteride—Rash—Vinorelbine—hematologic cancer	0.000169	0.000705	CcSEcCtD
Dutasteride—Dermatitis—Vinorelbine—hematologic cancer	0.000169	0.000704	CcSEcCtD
Dutasteride—Immune system disorder—Prednisone—hematologic cancer	0.000168	0.000698	CcSEcCtD
Dutasteride—Hypersensitivity—Vincristine—hematologic cancer	0.000168	0.000697	CcSEcCtD
Dutasteride—Pruritus—Alitretinoin—hematologic cancer	0.000167	0.000695	CcSEcCtD
Dutasteride—Pruritus—Ifosfamide—hematologic cancer	0.000165	0.000687	CcSEcCtD
Dutasteride—Dizziness—Thalidomide—hematologic cancer	0.000164	0.000682	CcSEcCtD
Dutasteride—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000163	0.000679	CcSEcCtD
Dutasteride—Hypersensitivity—Irinotecan—hematologic cancer	0.000163	0.000679	CcSEcCtD
Dutasteride—Mental disorder—Prednisone—hematologic cancer	0.000163	0.000677	CcSEcCtD
Dutasteride—Rash—Thiotepa—hematologic cancer	0.000162	0.000673	CcSEcCtD
Dutasteride—Dermatitis—Thiotepa—hematologic cancer	0.000162	0.000672	CcSEcCtD
Dutasteride—Dizziness—Carmustine—hematologic cancer	0.000158	0.000655	CcSEcCtD
Dutasteride—Rash—Thalidomide—hematologic cancer	0.000157	0.000651	CcSEcCtD
Dutasteride—Dermatitis—Thalidomide—hematologic cancer	0.000156	0.00065	CcSEcCtD
Dutasteride—Dizziness—Alitretinoin—hematologic cancer	0.000156	0.000649	CcSEcCtD
Dutasteride—Dizziness—Ifosfamide—hematologic cancer	0.000154	0.000642	CcSEcCtD
Dutasteride—Pruritus—Gemcitabine—hematologic cancer	0.000153	0.000635	CcSEcCtD
Dutasteride—Dizziness—Vincristine—hematologic cancer	0.000151	0.000626	CcSEcCtD
Dutasteride—Rash—Carmustine—hematologic cancer	0.00015	0.000625	CcSEcCtD
Dutasteride—Dermatitis—Carmustine—hematologic cancer	0.00015	0.000624	CcSEcCtD
Dutasteride—Rash—Alitretinoin—hematologic cancer	0.000149	0.000619	CcSEcCtD
Dutasteride—Dermatitis—Alitretinoin—hematologic cancer	0.000149	0.000619	CcSEcCtD
Dutasteride—Hypersensitivity—Cisplatin—hematologic cancer	0.000148	0.000616	CcSEcCtD
Dutasteride—Angioedema—Prednisone—hematologic cancer	0.000148	0.000615	CcSEcCtD
Dutasteride—Rash—Ifosfamide—hematologic cancer	0.000147	0.000612	CcSEcCtD
Dutasteride—Dermatitis—Ifosfamide—hematologic cancer	0.000147	0.000611	CcSEcCtD
Dutasteride—Dizziness—Irinotecan—hematologic cancer	0.000147	0.000609	CcSEcCtD
Dutasteride—Urticaria—Etoposide—hematologic cancer	0.000146	0.000609	CcSEcCtD
Dutasteride—Urticaria—Prednisolone—hematologic cancer	0.000144	0.000601	CcSEcCtD
Dutasteride—Rash—Vincristine—hematologic cancer	0.000144	0.000597	CcSEcCtD
Dutasteride—Dermatitis—Vincristine—hematologic cancer	0.000143	0.000596	CcSEcCtD
Dutasteride—Immune system disorder—Methotrexate—hematologic cancer	0.00014	0.000584	CcSEcCtD
Dutasteride—Rash—Irinotecan—hematologic cancer	0.00014	0.000581	CcSEcCtD
Dutasteride—Rash—Mitoxantrone—hematologic cancer	0.00014	0.000581	CcSEcCtD
Dutasteride—Dermatitis—Irinotecan—hematologic cancer	0.00014	0.00058	CcSEcCtD
Dutasteride—Dermatitis—Mitoxantrone—hematologic cancer	0.00014	0.00058	CcSEcCtD
Dutasteride—Mental disorder—Methotrexate—hematologic cancer	0.000136	0.000566	CcSEcCtD
Dutasteride—Rash—Gemcitabine—hematologic cancer	0.000136	0.000566	CcSEcCtD
Dutasteride—Dermatitis—Gemcitabine—hematologic cancer	0.000136	0.000565	CcSEcCtD
Dutasteride—Hypersensitivity—Etoposide—hematologic cancer	0.000136	0.000565	CcSEcCtD
Dutasteride—Hypersensitivity—Prednisolone—hematologic cancer	0.000134	0.000557	CcSEcCtD
Dutasteride—Urticaria—Triamcinolone—hematologic cancer	0.000133	0.000552	CcSEcCtD
Dutasteride—Immune system disorder—Epirubicin—hematologic cancer	0.000131	0.000546	CcSEcCtD
Dutasteride—Pruritus—Etoposide—hematologic cancer	0.00013	0.000542	CcSEcCtD
Dutasteride—Mental disorder—Epirubicin—hematologic cancer	0.000127	0.00053	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—HMMR—hematologic cancer	0.000127	0.00389	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—IDH2—hematologic cancer	0.000127	0.00389	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—IDH2—hematologic cancer	0.000127	0.00389	CbGpPWpGaD
Dutasteride—Rash—Cisplatin—hematologic cancer	0.000127	0.000528	CcSEcCtD
Dutasteride—Dermatitis—Cisplatin—hematologic cancer	0.000127	0.000527	CcSEcCtD
Dutasteride—Hypersensitivity—Triamcinolone—hematologic cancer	0.000123	0.000512	CcSEcCtD
Dutasteride—Dizziness—Etoposide—hematologic cancer	0.000122	0.000507	CcSEcCtD
Dutasteride—Immune system disorder—Doxorubicin—hematologic cancer	0.000122	0.000505	CcSEcCtD
Dutasteride—Urticaria—Betamethasone—hematologic cancer	0.000121	0.000501	CcSEcCtD
Dutasteride—Urticaria—Dexamethasone—hematologic cancer	0.000121	0.000501	CcSEcCtD
Dutasteride—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	0.000121	0.00368	CbGpPWpGaD
Dutasteride—Dizziness—Prednisolone—hematologic cancer	0.00012	0.0005	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.00012	0.00367	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.00012	0.00367	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ARNTL—hematologic cancer	0.00012	0.00366	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ARNTL—hematologic cancer	0.00012	0.00366	CbGpPWpGaD
Dutasteride—Pruritus—Triamcinolone—hematologic cancer	0.000118	0.000492	CcSEcCtD
Dutasteride—Mental disorder—Doxorubicin—hematologic cancer	0.000118	0.00049	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—CA9—hematologic cancer	0.000116	0.00356	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ACP5—hematologic cancer	0.000116	0.00356	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CA9—hematologic cancer	0.000116	0.00356	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ACP5—hematologic cancer	0.000116	0.00356	CbGpPWpGaD
Dutasteride—Rash—Etoposide—hematologic cancer	0.000116	0.000483	CcSEcCtD
Dutasteride—Dermatitis—Etoposide—hematologic cancer	0.000116	0.000483	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—NCOR2—hematologic cancer	0.000115	0.00351	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NCOR2—hematologic cancer	0.000115	0.00351	CbGpPWpGaD
Dutasteride—Rash—Prednisolone—hematologic cancer	0.000115	0.000477	CcSEcCtD
Dutasteride—Dermatitis—Prednisolone—hematologic cancer	0.000115	0.000476	CcSEcCtD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000113	0.00345	CbGpPWpGaD
Dutasteride—Dizziness—Triamcinolone—hematologic cancer	0.000111	0.00046	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—IDH1—hematologic cancer	0.000109	0.00334	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—IDH1—hematologic cancer	0.000109	0.00334	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTO1—hematologic cancer	0.000108	0.00331	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTO1—hematologic cancer	0.000108	0.00331	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—TXN—hematologic cancer	0.000108	0.00331	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ABCC3—hematologic cancer	0.000108	0.00331	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—TXN—hematologic cancer	0.000108	0.00331	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ABCC3—hematologic cancer	0.000108	0.00331	CbGpPWpGaD
Dutasteride—Pruritus—Dexamethasone—hematologic cancer	0.000107	0.000446	CcSEcCtD
Dutasteride—Pruritus—Betamethasone—hematologic cancer	0.000107	0.000446	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—SPHK1—hematologic cancer	0.000106	0.00324	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SPHK1—hematologic cancer	0.000106	0.00324	CbGpPWpGaD
Dutasteride—Rash—Triamcinolone—hematologic cancer	0.000105	0.000438	CcSEcCtD
Dutasteride—Dermatitis—Triamcinolone—hematologic cancer	0.000105	0.000438	CcSEcCtD
Dutasteride—Urticaria—Prednisone—hematologic cancer	0.000105	0.000436	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—UGT1A1—hematologic cancer	0.000102	0.00311	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—UGT1A1—hematologic cancer	0.000102	0.00311	CbGpPWpGaD
Dutasteride—Dizziness—Dexamethasone—hematologic cancer	0.0001	0.000417	CcSEcCtD
Dutasteride—Dizziness—Betamethasone—hematologic cancer	0.0001	0.000417	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—CRABP1—hematologic cancer	9.9e-05	0.00302	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CRABP1—hematologic cancer	9.9e-05	0.00302	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC22A1—hematologic cancer	9.9e-05	0.00302	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SLC22A1—hematologic cancer	9.9e-05	0.00302	CbGpPWpGaD
Dutasteride—Hypersensitivity—Prednisone—hematologic cancer	9.74e-05	0.000405	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—ALOX5—hematologic cancer	9.65e-05	0.00295	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ALOX5—hematologic cancer	9.65e-05	0.00295	CbGpPWpGaD
Dutasteride—Rash—Betamethasone—hematologic cancer	9.57e-05	0.000398	CcSEcCtD
Dutasteride—Rash—Dexamethasone—hematologic cancer	9.57e-05	0.000398	CcSEcCtD
Dutasteride—Dermatitis—Dexamethasone—hematologic cancer	9.56e-05	0.000397	CcSEcCtD
Dutasteride—Dermatitis—Betamethasone—hematologic cancer	9.56e-05	0.000397	CcSEcCtD
Dutasteride—Pruritus—Prednisone—hematologic cancer	9.35e-05	0.000389	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—NUP98—hematologic cancer	9.34e-05	0.00285	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NUP98—hematologic cancer	9.34e-05	0.00285	CbGpPWpGaD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	9.33e-05	0.00285	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ADCY7—hematologic cancer	9.07e-05	0.00277	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ADCY7—hematologic cancer	9.07e-05	0.00277	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NCOA3—hematologic cancer	9.07e-05	0.00277	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NCOA3—hematologic cancer	9.07e-05	0.00277	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NUP214—hematologic cancer	9.01e-05	0.00275	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NUP214—hematologic cancer	9.01e-05	0.00275	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.91e-05	0.00272	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.91e-05	0.00272	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—MTR—hematologic cancer	8.82e-05	0.00269	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ABCG2—hematologic cancer	8.82e-05	0.00269	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ABCG2—hematologic cancer	8.82e-05	0.00269	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—MTR—hematologic cancer	8.82e-05	0.00269	CbGpPWpGaD
Dutasteride—Urticaria—Methotrexate—hematologic cancer	8.77e-05	0.000365	CcSEcCtD
Dutasteride—Dizziness—Prednisone—hematologic cancer	8.74e-05	0.000363	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—ENO2—hematologic cancer	8.65e-05	0.00264	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ENO2—hematologic cancer	8.65e-05	0.00264	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTO1—hematologic cancer	8.63e-05	0.00264	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTO1—hematologic cancer	8.51e-05	0.0026	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTT1—hematologic cancer	8.39e-05	0.00256	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTT1—hematologic cancer	8.39e-05	0.00256	CbGpPWpGaD
Dutasteride—Rash—Prednisone—hematologic cancer	8.33e-05	0.000346	CcSEcCtD
Dutasteride—Dermatitis—Prednisone—hematologic cancer	8.32e-05	0.000346	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.26e-05	0.00252	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.26e-05	0.00252	CbGpPWpGaD
Dutasteride—Urticaria—Epirubicin—hematologic cancer	8.21e-05	0.000341	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—SDC1—hematologic cancer	8.2e-05	0.00251	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SDC1—hematologic cancer	8.2e-05	0.00251	CbGpPWpGaD
Dutasteride—Hypersensitivity—Methotrexate—hematologic cancer	8.14e-05	0.000338	CcSEcCtD
Dutasteride—CYP3A5—Biological oxidations—UGT1A1—hematologic cancer	8.11e-05	0.00248	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—UGT1A1—hematologic cancer	8e-05	0.00244	CbGpPWpGaD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	7.84e-05	0.00239	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.84e-05	0.00239	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.84e-05	0.00239	CbGpPWpGaD
Dutasteride—Pruritus—Methotrexate—hematologic cancer	7.81e-05	0.000325	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.74e-05	0.00236	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.74e-05	0.00236	CbGpPWpGaD
Dutasteride—Hypersensitivity—Epirubicin—hematologic cancer	7.61e-05	0.000317	CcSEcCtD
Dutasteride—Urticaria—Doxorubicin—hematologic cancer	7.6e-05	0.000316	CcSEcCtD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	7.47e-05	0.00228	CbGpPWpGaD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	7.41e-05	0.00226	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.4e-05	0.00226	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.4e-05	0.00226	CbGpPWpGaD
Dutasteride—Pruritus—Epirubicin—hematologic cancer	7.31e-05	0.000304	CcSEcCtD
Dutasteride—Dizziness—Methotrexate—hematologic cancer	7.3e-05	0.000304	CcSEcCtD
Dutasteride—Hypersensitivity—Doxorubicin—hematologic cancer	7.05e-05	0.000293	CcSEcCtD
Dutasteride—CYP3A5—Biological oxidations—MTR—hematologic cancer	7.03e-05	0.00215	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CD44—hematologic cancer	6.98e-05	0.00213	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NQO1—hematologic cancer	6.98e-05	0.00213	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NQO1—hematologic cancer	6.98e-05	0.00213	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CD44—hematologic cancer	6.98e-05	0.00213	CbGpPWpGaD
Dutasteride—Rash—Methotrexate—hematologic cancer	6.96e-05	0.000289	CcSEcCtD
Dutasteride—Dermatitis—Methotrexate—hematologic cancer	6.96e-05	0.000289	CcSEcCtD
Dutasteride—Dizziness—Epirubicin—hematologic cancer	6.83e-05	0.000284	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.83e-05	0.00209	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.83e-05	0.00209	CbGpPWpGaD
Dutasteride—Pruritus—Doxorubicin—hematologic cancer	6.77e-05	0.000281	CcSEcCtD
Dutasteride—CYP3A5—Biological oxidations—GSTT1—hematologic cancer	6.69e-05	0.00204	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYCS—hematologic cancer	6.6e-05	0.00202	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYCS—hematologic cancer	6.6e-05	0.00202	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—HSP90AA1—hematologic cancer	6.56e-05	0.002	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—HSP90AA1—hematologic cancer	6.56e-05	0.002	CbGpPWpGaD
Dutasteride—Rash—Epirubicin—hematologic cancer	6.52e-05	0.000271	CcSEcCtD
Dutasteride—Dermatitis—Epirubicin—hematologic cancer	6.51e-05	0.000271	CcSEcCtD
Dutasteride—Dizziness—Doxorubicin—hematologic cancer	6.32e-05	0.000263	CcSEcCtD
Dutasteride—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	6.23e-05	0.0019	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	6.14e-05	0.00188	CbGpPWpGaD
Dutasteride—Rash—Doxorubicin—hematologic cancer	6.03e-05	0.000251	CcSEcCtD
Dutasteride—Dermatitis—Doxorubicin—hematologic cancer	6.02e-05	0.00025	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.9e-05	0.0018	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.9e-05	0.0018	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTP1—hematologic cancer	5.82e-05	0.00178	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTP1—hematologic cancer	5.82e-05	0.00178	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.63e-05	0.00172	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.63e-05	0.00172	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ABCB1—hematologic cancer	5.51e-05	0.00168	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ABCB1—hematologic cancer	5.51e-05	0.00168	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTM1—hematologic cancer	5.35e-05	0.00163	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTM1—hematologic cancer	5.35e-05	0.00163	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NCOR1—hematologic cancer	5.35e-05	0.00163	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NCOR1—hematologic cancer	5.35e-05	0.00163	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—MTHFR—hematologic cancer	4.72e-05	0.00144	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—MTHFR—hematologic cancer	4.72e-05	0.00144	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTP1—hematologic cancer	4.64e-05	0.00142	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTP1—hematologic cancer	4.57e-05	0.0014	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTM1—hematologic cancer	4.26e-05	0.0013	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTM1—hematologic cancer	4.2e-05	0.00128	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.16e-05	0.00127	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.16e-05	0.00127	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	4.01e-05	0.00123	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CG—hematologic cancer	3.97e-05	0.00121	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CG—hematologic cancer	3.97e-05	0.00121	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	3.96e-05	0.00121	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	3.77e-05	0.00115	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	3.72e-05	0.00114	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CREBBP—hematologic cancer	3.68e-05	0.00112	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CREBBP—hematologic cancer	3.68e-05	0.00112	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GMPS—hematologic cancer	3.55e-05	0.00109	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—FTCD—hematologic cancer	3.55e-05	0.00109	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PHYH—hematologic cancer	3.55e-05	0.00109	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CD—hematologic cancer	3.49e-05	0.00107	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CD—hematologic cancer	3.49e-05	0.00107	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ALB—hematologic cancer	3.45e-05	0.00105	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ALB—hematologic cancer	3.45e-05	0.00105	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	3.33e-05	0.00102	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3R1—hematologic cancer	3.3e-05	0.00101	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3R1—hematologic cancer	3.3e-05	0.00101	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—MTR—hematologic cancer	3.27e-05	0.000999	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SMPD3—hematologic cancer	3.25e-05	0.000993	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.11e-05	0.00095	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CB—hematologic cancer	3.04e-05	0.000929	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CB—hematologic cancer	3.04e-05	0.000929	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—B3GAT1—hematologic cancer	2.84e-05	0.000868	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ASNS—hematologic cancer	2.84e-05	0.000868	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—DCK—hematologic cancer	2.84e-05	0.000868	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HDC—hematologic cancer	2.69e-05	0.000823	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTEN—hematologic cancer	2.63e-05	0.000803	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTEN—hematologic cancer	2.63e-05	0.000803	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—EP300—hematologic cancer	2.51e-05	0.000766	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—EP300—hematologic cancer	2.51e-05	0.000766	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CDA—hematologic cancer	2.46e-05	0.000752	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PC—hematologic cancer	2.37e-05	0.000724	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC35B2—hematologic cancer	2.29e-05	0.000699	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GBA—hematologic cancer	2.29e-05	0.000699	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.16e-05	0.000658	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.13e-05	0.000649	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MTAP—hematologic cancer	2.09e-05	0.00064	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.98e-05	0.000605	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.95e-05	0.000597	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—FHL2—hematologic cancer	1.87e-05	0.00057	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CA—hematologic cancer	1.85e-05	0.000566	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CA—hematologic cancer	1.85e-05	0.000566	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AGRN—hematologic cancer	1.83e-05	0.000559	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—IDH2—hematologic cancer	1.74e-05	0.00053	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HMMR—hematologic cancer	1.74e-05	0.00053	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GMPS—hematologic cancer	1.65e-05	0.000505	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PHYH—hematologic cancer	1.65e-05	0.000505	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—FTCD—hematologic cancer	1.65e-05	0.000505	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.63e-05	0.000498	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CA9—hematologic cancer	1.59e-05	0.000485	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ACP5—hematologic cancer	1.59e-05	0.000485	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOR2—hematologic cancer	1.57e-05	0.000478	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—AKT1—hematologic cancer	1.51e-05	0.000463	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AKT1—hematologic cancer	1.51e-05	0.000463	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.51e-05	0.000461	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—IDH1—hematologic cancer	1.49e-05	0.000456	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTO1—hematologic cancer	1.48e-05	0.000451	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCC3—hematologic cancer	1.48e-05	0.000451	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—TXN—hematologic cancer	1.48e-05	0.000451	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SPHK1—hematologic cancer	1.44e-05	0.000441	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1.39e-05	0.000424	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CRABP1—hematologic cancer	1.35e-05	0.000412	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC22A1—hematologic cancer	1.35e-05	0.000412	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ASNS—hematologic cancer	1.32e-05	0.000403	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—DCK—hematologic cancer	1.32e-05	0.000403	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.32e-05	0.000403	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.32e-05	0.000402	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NUP98—hematologic cancer	1.27e-05	0.000389	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HDC—hematologic cancer	1.25e-05	0.000382	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ADCY7—hematologic cancer	1.24e-05	0.000378	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOA3—hematologic cancer	1.24e-05	0.000378	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NUP214—hematologic cancer	1.23e-05	0.000375	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCG2—hematologic cancer	1.2e-05	0.000367	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MTR—hematologic cancer	1.2e-05	0.000367	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ENO2—hematologic cancer	1.18e-05	0.00036	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CDA—hematologic cancer	1.15e-05	0.00035	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTT1—hematologic cancer	1.14e-05	0.000349	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SDC1—hematologic cancer	1.12e-05	0.000342	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PC—hematologic cancer	1.1e-05	0.000337	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GBA—hematologic cancer	1.06e-05	0.000325	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.06e-05	0.000325	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MTAP—hematologic cancer	9.74e-06	0.000297	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NQO1—hematologic cancer	9.51e-06	0.00029	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CD44—hematologic cancer	9.51e-06	0.00029	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYCS—hematologic cancer	9e-06	0.000275	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	8.94e-06	0.000273	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—FHL2—hematologic cancer	8.68e-06	0.000265	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AGRN—hematologic cancer	8.51e-06	0.00026	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HMMR—hematologic cancer	8.07e-06	0.000246	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—IDH2—hematologic cancer	8.07e-06	0.000246	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTP1—hematologic cancer	7.93e-06	0.000242	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ARNTL—hematologic cancer	7.59e-06	0.000232	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCB1—hematologic cancer	7.51e-06	0.000229	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CA9—hematologic cancer	7.38e-06	0.000225	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ACP5—hematologic cancer	7.38e-06	0.000225	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOR1—hematologic cancer	7.29e-06	0.000223	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTM1—hematologic cancer	7.29e-06	0.000223	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.28e-06	0.000222	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—IDH1—hematologic cancer	6.94e-06	0.000212	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.86e-06	0.00021	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TXN—hematologic cancer	6.86e-06	0.00021	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.86e-06	0.00021	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.71e-06	0.000205	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.45e-06	0.000197	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MTHFR—hematologic cancer	6.44e-06	0.000197	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.27e-06	0.000192	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.27e-06	0.000192	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.11e-06	0.000187	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NUP98—hematologic cancer	5.92e-06	0.000181	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.75e-06	0.000176	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.75e-06	0.000176	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NUP214—hematologic cancer	5.71e-06	0.000174	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MTR—hematologic cancer	5.59e-06	0.000171	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.59e-06	0.000171	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ENO2—hematologic cancer	5.48e-06	0.000167	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CG—hematologic cancer	5.41e-06	0.000165	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.32e-06	0.000162	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SDC1—hematologic cancer	5.2e-06	0.000159	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CREBBP—hematologic cancer	5.02e-06	0.000153	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CD—hematologic cancer	4.76e-06	0.000145	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALB—hematologic cancer	4.7e-06	0.000143	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3R1—hematologic cancer	4.49e-06	0.000137	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CD44—hematologic cancer	4.42e-06	0.000135	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NQO1—hematologic cancer	4.42e-06	0.000135	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYCS—hematologic cancer	4.18e-06	0.000128	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.16e-06	0.000127	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CB—hematologic cancer	4.15e-06	0.000127	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.69e-06	0.000113	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTEN—hematologic cancer	3.58e-06	0.000109	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.49e-06	0.000107	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—EP300—hematologic cancer	3.42e-06	0.000104	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.39e-06	0.000103	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.39e-06	0.000103	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.99e-06	9.15e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.53e-06	7.72e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.52e-06	7.68e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.33e-06	7.12e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.21e-06	6.75e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALB—hematologic cancer	2.18e-06	6.67e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.09e-06	6.38e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AKT1—hematologic cancer	2.06e-06	6.31e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.93e-06	5.89e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTEN—hematologic cancer	1.67e-06	5.09e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—EP300—hematologic cancer	1.59e-06	4.85e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.18e-06	3.59e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AKT1—hematologic cancer	9.6e-07	2.93e-05	CbGpPWpGaD
